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ABSTRAK  
 
       Madu adalah produk semulajadi bernutrisi tinggi yang digunakan secara meluas dalam 
bidang terapi perubatan sejak zaman dahulu lagi. Dalam kajian ini, keberkesanan madu 
lebah Tualang dalam mengurangkan komplikasi menopaus mengunakan tikus betina yang 
telah diovariektomi dua belah. Dalam kajian I (kajian pendek dua minggu), tikus 
dibahagikan secara rawak kepada lima kumpulan (n=7), terdiri daripada kumpulan dibedah 
sham (SHAM), kawalan ovariektomi (OVX), kumpulan ovariektomi THL (diberi 0.2 g/kg 
madu Tualang), kumpulan ovariektomi THM (diberi 1.0 g/kg madu Tualang) dan 
kumpulan ovariektomi THH (diberi 2.0 g/kg madu Tualang). Kedua-dua kumpulan SHAM 
dan OVX diberi rawatan 0.5 ml air suling. Rawatan diberi secara oral gavaj setiap hari 
selama dua minggu. Organ pembiakan (uterus dan vagina) dan tulang tibia diambil untuk 
pemeriksaan histopatologi manakala serum untuk analisis hormon. Rawatan madu Tualang 
selama dua minggu kepada tikus ovariektomi secara signifikan (P<0.05) meningkatkan 
berat uterus dan vagina (P<0.05), meningkatkan ketebalan lapisan epithelium dan otot 
vagina (P<0.05), meningkatkan ketebalan lapisan endometrium dan otot myometrium 
uterus (P<0.05), memulihkan ketebalan tulang trabekular tibia and menurunkan berat badan 
(P<0.05) berbanding kumpulan kawalan OVX. Tiada perbezaan signifikan (P>0.05) untuk 
profil hormon kecuali aras testosterone (P<0.05). Dalam kajian II (kajian dos ulangan enam 
minggu), tikus dibahagikan secara rawak kepada lima kumpulan (n=8) yang terdiri 
daripada kumpulan kawalan asas (BC; tidak diovariektomi atau dibedah sham), kumpulan 
dibedah sham (SHAM), kawalan ovariektomi (OVX), kumpulan rawatan madu Tualang 
(TH; diberi 0.2 g/kg madu Tualang) dan kumpulan kawalan positif (PC; diberi 1% kalsium 
dalam air minuman). Kedua-dua kumpulan SHAM dan OVX diberi rawatan 0.5 ml air 
 xiii
ternyahion. Rawatan selama enam minggu diberikan secara oral gavaj setiap hari iaitu 
bermula 14 hari selepas pembedahan dilakukan. Tulang femur diambil untuk pemeriksaan 
histopatologi manakala serum untuk analisis aras glukos. Rawatan madu Tualang selama 
enam minggu kepada tikus-tikus diovariektomi, analisis histomorphometri menunjukkan 
secara signifikan meningkatkan isipadu tulang per isipadu tisu (BV/TV) (P<0.05), 
ketebalan trabecular (Tb.Th) (P<0.05) dan bilangan trabecular (Tb.N) (P<0.05) termasuklah 
merendahkan jarak pemisahan trabecular (Tb.Sp) (P<0.05) berbanding dengan kumpulan 
OVX. Aras glukos didapati tidak berubah dengan signifikan (P>0.05) dalam semua 
kumpulan menunjukkan ovariektomi dan rawatan madu selama enam minggu tidak 
mempengaruhi sensitiviti insulin dalam sistem badan. Kesimpulan, madu Tualang berkesan 
dalam merawat gejala menopaus seperti mengurangkan keadaan atropi sistem reproduktif 
dan memelihara jisim tulang dalam model haiwan menopaus.   
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ABSTRACT 
 
       Honey is a highly nutritional natural product that has been widely used in the folk 
medicine for a number of therapeutic purposes. In this study, Tualang honey was evaluated 
for its effectiveness in reducing postmenopausal changes in bilaterally ovariectomised rats. 
In study I (short term two weeks study), rats were randomly divided into five groups (n=7), 
which were the of sham control group (SHAM), ovariectomised control group (OVX), 
THL ovariectomised group (received 0.2 g/kg of Tualang honey), THM ovariectomised 
group (received 1.0 g/kg of Tualang honey) and THH ovariectomised group (received 2.0 
g/kg of Tualang honey). Both SHAM and OVX groups received 0.5 ml vehicle treatment of 
distilled water. The treatment was given orally by gavage daily for two weeks. The 
reproductive organs (uterus and vagina) and tibia bone were subjected to histopathological 
examination while the serum was for hormonal assays. Administration of Tualang honey 
for two weeks to ovariectomised rats significantly increased the weight of the uterus and 
vagina (P<0.05), increased the thickness of vaginal epithelium and muscular layers 
(P<0.05), increased the thickness of uterine endometrium and myometrium layers (P<0.05), 
restored the thickness of trabecular tibia bone and suppressed the body weight (P<0.05) 
compared to OVX group. There were no significant changes in hormonal profile except for 
free testosterone level (P<0.05). In study II (six weeks repeated dose study), rats were 
randomly divided into five groups according to body weight (n=8) consists of baseline 
control group (BC; not subjected to ovariectomy or sham-operation and killed without 
treatment), sham control group (SHAM), ovariectomised control group (OVX), Tualang 
honey treated group (TH; received 0.2 g/kg of Tualang honey) and positive control (PC; 
received 1% calcium in drinking water). Both SHAM and OVX groups received vehicle 
 xv
 xvi
treatment 0.5 ml of deionized water. The treatment was given by gavaging daily from day 
14 post-operative for six weeks duration. The femur bone was taken for histopathological 
examination while serum for blood fasting glucose assay. After six weeks administration of 
Tualang honey to ovariectomised rats, histomorphometrical analysis of bone structures 
showed significant increase in the bone volume per tissue volume (BV/TV) (P<0.05), the 
trabecular bone thickness (Tb.Th) (P<0.05) and the trabecular bone number (Tb.N) 
(P<0.05), as well as significant lower in trabecular bone separation (Tb.Sp) (P>0.05) 
compared with OVX group. There were no significant changes in the fasting blood glucose 
levels (P<0.05) indicating that ovariectomy and six weeks treatment with honey did not 
influent the body sensitivity of towards insulin. In conclusion, Tualang honey improved the 
histology of atrophic reproductive organs and restored the bone mass in postmenopausal 
(bilateral ovariectomy) animal model.  
 
CHAPTER ONE  
 
INTRODUCTION 
 
1.1 INTRODUCTION       
  
       Menopause is the time of life in women when menstrual cycles and reproductive 
function permanently cease due to the loss of ovarian follicular activity (Amore et al., 
2007; Hunter and Rendall, 2007; Jahangar et al., 2006; Stoppard, 1994). Clinically, natural 
menopause can be diagnosed in women in their 40s or 50s after 12 consecutive months of 
amenorrhea for which no other obvious pathological or physiological cause can be found 
(Wich and Carnes, 1995; Harlow and Signorello, 2000). However, it can also be induced by 
surgery, chemotherapy, or radiation (Harris et al., 2002; Stoppard, 1994).  
        
       There are various early and late complications of menopausal period frequently 
referred to as postmenopausal syndrome such as vasomotor, psychogenic and sexual 
problems while other complications which could occur much later include increase in 
incidence of atherosclerosis, ischemic heart disease, stroke and osteoporosis (Mori-
Okamoto et al., 2004; Boreham et al., 2002; Avis et al., 2005; Kanis et al., 1991; Stoppard, 
1994). In order to reduce these complications, hormone replacement therapy (HRT) has 
been prescribed extensively over the last 25 years (Blumberg et al., 1996). Findings from 
the Women’s Health Initiative  trial suggested that long-term HRT use increases the risk of 
breast cancer, endometrial cancer, thromboembolic events and vaginal bleeding (Termine 
and Wong, 1998). Such findings have resulted in a search for HRT alternatives and natural 
products therapies for postmenopausal complications. In fact, women need to approach the 
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transition into menopause in a holistic and integrative way by managing menopause in 
terms of the entire lifestyle, including eating correctly, using the correct supplements, dress 
management and healing herbs or natural products to assist gently through the menopause 
and perimenopause. 
 
        Honey is a natural product that has been widely used for its therapeutic benefits 
(Molan and Allen, 1996). It has been reported to contain about 200 substances such as 
mixture of sugars (fructose, glucose, maltose and sucrose) and also small amounts of other 
constituents such as minerals, proteins, vitamins, organic acids, flavonoids, phenolic acids, 
enzymes and other phytochemicals (Aljadi and Kamaruddin, 2004; Al-Mamary et al., 
2002; Beretta et al., 2007; Bergman et al., 1983; Bertoncelj et al., 2007; Blasa et al., 2006; 
Blasa et al., 2007; Chen et al., 2000; Cooper et al., 2001; Dustmann, 1979; Frankel et al., 
1998; Gheldof et al., 2002; Ibrahim, 1981; McInerney, 1990).  However, the nutritional 
profiles of honey are qualitatively and quantitatively variable depending on the regional 
plant ecology (Al-Mamary et al., 2002). It is known to have some pharmacological 
functions in human such as anti inflammatory (Armon, 1980; Bergman et al., 1983; 
Blomfield, 1973), antibacterial, immunomodulatory and antioxidant (Beretta et al., 2007; 
Blasa et al., 2007; Chen et al., 2000). In Malaysia, honey has been used by local folk 
people during postpartum and postmenopausal period (usually with yolk egg) to improve 
health and to enhance vitality. Royal jelly and propolis are other beehive products that have 
been scientifically proven for their improvement of menopausal syndrome (Mishima et al., 
2005; Song et al., 2002). Tualang honey is a wild honey in which the bees of the Apis 
Dorsata species form hives on the branch on tall trees named Tualang, found in the 
Malaysian Rain Forest in Malaysia.  
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       Thus far, there are no data on the benefits of honey on postmenopausal syndrome. 
Hence a study to evaluate the effect of Tualang honey (AgroMas, Malaysia) on the 
reproductive system and bone using bilateral ovariectomised rats as postmenopausal animal 
model was conducted. According to previous researchers, ovariectomised female rats with 
or without supplementation of hormones are widely used as animal models to study the 
impact of hormones on physiological changes (Goss et al., 2004; Mori-Okamoto et al., 
2004; Bradshaw and Berkley, 2002) and osteoporosis (Nazrun et al., 2007; Kalu, 1991) that 
may occur during postmenopausal period. A short term two weeks study (Study I) and a six 
weeks repeated dose study (Study II) were conducted to evaluate the effects of honey 
supplementation on the reproductive system and bone properties in ovariectomised rats.  
 
       During the short term two weeks study (study I) honey supplementation was given 
immediately following ovariectomy and the reproductive organs (uterus and vagina) and 
hormonal profiles were studied. The undecalcified histology of the bone was reviewed 
under the microscope. More detailed study on the bone was done following six weeks 
repeated dose honey treatment (study II). In this study the animals were ovariectomised and 
two weeks later, honey was administered. Calcium supplementation was given to the 
positive control group to compare the effects of honey administration with calcium 
supplementation. Blood was also collected in this study to see the effect of honey 
supplementation on fasting blood glucose in ovariectomised rats. 
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1.2 OBJECTIVES OF THE STUDY 
 
1.2.1 Study I - Short term two weeks study 
 
1.2.1.1 General objectives 
 
       The objective of the study is to determine the effects of two weeks administration of 
Tualang honey (AgroMas, Malaysia) on the reproductive system and bone in 
ovariectomised rats (postmenopausal animal model).  
 
1.2.1.2 Specific objectives 
 
a)  To determine the histomorphological effects of Tualang honey on the histomorphology 
the of uterus and vagina of ovariectomised rats. 
b) To determine the effects of Tualang honey on reproductive hormones (17ß-estradiol, 
progesterone, free testosterone, FSH and LH) of ovariectomised rats. 
c)  To determine the effects of Tualang honey on the weight and morphology of tibia bone 
of ovariectomised rats. 
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1.2.2 Study II - Six weeks repeated dose study 
 
 
1.2.2.1 General objectives 
 
       The general objective of the study is to determine the effects of longer period (six 
weeks) administration of Tualang honey (AgroMas, Malaysia) on bone properties and 
fasting blood glucose levels in ovariectomised rats (postmenopausal animal model).  
 
1.2.2.2 The specific objectives  
 
1) To determine the effects of Tualang honey on trabecular bone volume of ovariectomised 
rats. 
2) To determine the effects of Tualang honey on trabecular bone thickness of 
ovariectomised rats. 
3) To determine the effects of Tualang honey on trabecular bone number of ovariectomised 
rats. 
4) To determine the effects of Tualang honey on trabecular bone separation of 
ovariectomised rats. 
5) To determine the effects of Tualang honey on fasting blood glucose levels of 
ovariectomised rats. 
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1.3 HYPOTHESIS OF THE STUDY 
 
1.3.1 Study I - Short term two weeks study 
 
1.3.1.1) Ovariectomy causes regression of the morphology of reproductive organs (uterus 
and vagina) of rats due to estrogen deficiency and administration of Tualang honey 
improves the morphology of both organs in ovariectomised rats. 
1.3.1.2) Ovariectomy disturbs the normal levels of reproductive hormones and 
administration of Tualang honey improves the hormonal levels of these hormones in 
ovariectomised rats. 
1.3.1.3) Ovariectomy reduces the trabecular bone thickness due to estrogen deficiency and 
administration of Tualang honey restores this thickness in ovariectomised rats. 
 
1.3.2 Study II- Six weeks repeated dose study  
 
1.3.2.1)  Ovariectomy causes regression structure of trabecular bone and administration of 
Tualang honey restores regression structure of trabecular bone in ovariectomised rats. 
1.3.2.2) Administration of Tualang honey maintains the normal levels of fasting blood 
glucose in ovariectomised rats. 
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1.4 Significance of the study  
 
       Tualang honey (AgroMas, Malaysia) is a natural bioproduct that has not been 
extensively evaluated for its nutritional and medicinal properties. Thus, this study provides 
scientific information on the benefit of local Tualang honey as nutritional or nutraceutical 
products in preventing postmenopausal changes using ovariectomised rat as 
postmenopausal animal model. 
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CHAPTER TWO  
LITERATURE REVIEW 
 
2.1 HONEY 
 
2.1.1 Sources and biochemical profile of honey 
 
       Honey is a sweet natural substance that contains a highly concentrated solution of a 
complex mixture of sugars produced by honeybees (of the Apis genus) in almost every 
country of the world and extracted generally from nectars (Blasa et al., 2006; Gomez-
Caravaca et al., 2006). The main effect of nectar collecting by bees from various plants and 
flowers is pollination, which is crucial for flowering plants. Honey has been used 
extensively since ancient times and has been appreciated as the only concentrated form of 
sugar available worldwide (Nagai et al., 2001).  
 
       Previous works have indicated that the composition of honey varies widely according 
to the floral source and geographical origin, climate, environmental condition and post-
harvest processing condition such as processing, handling and storage (Cherchi et al., 1994; 
Gheldof and Engeseth, 2002; Frankel et al., 1998; Gheldof et al., 2002; Turkmen et al., 
2006; Al-Mamary et al., 2002; Beretta et al., 2005; Chen et al., 2000; Yao et al., 2004; 
Kucuk et al., 2007). A study has shown that the Italian honey collected from the nectar of 
wild blossoms on hill zones and mountain zones is contains higher organoleptic 
characteristics and nourishing values, low moisture content, high density and has a stability 
which guarantees long shelf live without the risk of fermentation or changes in its 
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properties (Blasa et al., 2006). Multifloral honey differs from unifloral honey in that it is 
darker in color with solid crystallization and is thick while unifloral honey has light color, 
transparent appearance and is thin (Blasa et al., 2006). The color of honey is affected by the 
content of minerals, pollens and phenolics (Baltrusaityte et al., 2007; Lazaridou et al., 
2004). Darkening of honey during storage may occur due to Maillard reactions, fructose 
caramelization and reactions of polyphenols as well as temperature and/or time of storage 
(Bertoncelj et al., 2007). These compositional differences can influence the value of a 
specific honey for medicinal or health-promoting purposes (Gomez-Caravaca et al., 2006). 
However, the main constituents of all honey from all countries of the world are almost 
similar.  
 
       Honey, a supersaturated aqueous solution of inverted sugars mainly contains fructose 
(38%) and glucose (31%) as well as a small amount of very complex mixture of other 
saccharides such as disaccharides, trisaccharides and oligosaccharides. It also contains 
small amounts of enzymes, amino and organic acids, phytochemicals, carotenoid-like 
substances, Maillard reaction products, vitamins and minerals (Cherchi et al., 1994; Antony 
et al., 2000; Blasa et al., 2006; Bertoncelj et al., 2007; Vit et al., 1997; Gomez-Caravaca et 
al., 2006). The average composition of honey is given in Table 2.1. Honey is considered to 
be a suitable food for humans of every age due to its high nutritional value (304 kcal/100 g 
honey) and fast absorption of its carbohydrates. Honey is recommended as a supplement 
for children and sportsmen and used by itself or with appropriate therapies to help improve 
the efficiency of the elderly and invalids. It has a density of about 1.36 kg/liter (40% denser 
than water), with acidic environment ranging from 3.2 to 4.5 pH and high osmotic pressure 
and low water activity (Jeffrey and Echazareta, 1996). Raw honeys are usually produced by 
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small farms and left in their natural state without undergoing processing to thermal or 
pasteurization processes or any other operations to alter their natural composition. 
However, the extraneous matter that is contained in raw honey is removed in order to make 
it marketable on a large scale (Blasa et al., 2006).   
 
      The main enzymes found in honey which are derived from the hypopharyngeal glands 
of worker honeybees are invertase, diastase (amylase), catalase, glucose oxidase and acid 
phosphatase (Jeffrey and Echazareta, 1996). Invertase is added to the nectar by the 
honeybees as either fructo-invertase or gluco-invertase that converts sucrose to fructose or 
glucose. However, this enzyme becomes inactive with high temperatures.  Diastase 
originating from honeybees and pollen can breakdown or split the starch chains to 
randomly produce dextrins and maltose and can change to inactive forms after long periods 
of storage and exposure to high temperature. Catalase functions as a regulator of glucose 
oxidase activity and produces oxygen and water from hydrogen peroxide.The inverse 
relationship between catalase activity and hydrogen peroxide content has been used as an 
indicator for hydrogen peroxide level in honey, formerly known as ‘inhibine number’. The 
glucose oxidase enzyme is of considerable interest because its activity causes the 
production of hydrogen peroxide which not only stablizes the ripening nectar against 
spoilage but has microbicidal action.  
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Table 2.1 Nutrient values of honey adopted from National Honey Board, 2002. 
 
 
Nutrient                                        Average amount per                        Average amount  
                                                     1 Tbsp serving (21g)                              per 100g 
 
Water                                                       3.62g                                             17.10g        
Calories                                                   64                                                   304 
Total Carbohydrate                                 17.46g                                            82.40g 
     Fructose                                              8.16g                                             38.50g 
     Glucose                                              6.57g                                              31.00g 
     Maltose                                              1.53g                                              7.20g 
     Sucrose                                               0.32g                                             1.50g 
     Other carbohydrates                           0.85g                                             4.00g 
Dietary fiber                                            0.04g                                             0.20g 
Total fat                                                   0                                                    0 
Cholesterol                                              0                                                    0 
Total protein                                            0.06g                                             0.30g 
Ash                                                          0.04g                                             0.20g 
Vitamins 
(data not available for biotin and vitamin B-12) 
    Thiamin                                               0                                                    0 
    Riboflavin                                           0.01mg                                          0.04mg 
    Niacin                                                  0.03mg                                          0.12mg 
    Pantothenic acid                                  0.01mg                                          0.07mg 
    Vitamin B-6                                        0.01mg                                          0.02mg 
    Vitamin B-12                                      0                                                    0 
    Folate                                                  0.42mcg                                        2.00mcg 
    Vitamin C                                           0.11mg                                          0.50mg 
    Vitamin A                                           0                                                    0 
    Vitamin D                                           0                                                    0 
    Vitamin E                                           0                                                     0 
    Vitamin K                                           0                                                    0 
Minerals 
    Calcium                                              1.27g                                             6.00mg 
    Phosphorus                                         0.85g                                             4.00mg 
    Sodium                                               0.85mg                                          4.00mg 
    Potassium                                           11.02mg                                        52.00mg 
    Iron                                                     0.09mg                                         0.42mg 
    Zinc                                                    0.05mg                                         0.22m 
    Magnesium                                        0.42mg                                          2.00mg 
    Selenium                                            0.17mg                                          0.80mg 
    Copper                                               0.01mg                                          0.04mg 
    Manganese                                         0.02mg                                          0.08mg 
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       Honey contains a number of amino acids such as proline, lysine, phenylalanine, 
tyrosine, glutamic and aspartic acids (Jeffrey and Echazareta, 1996) which are contributed 
by the pollens, nectar or by honeybees themselves. The predominant organic acid in honey 
is gluconic acid while the others are butyric, acetic, formic, lactic, succinic, malic, citric, 
maleic, oxalic and pyroglutamic. Gluconic acid in honey originates largely from the 
activity of enzymatic glucose oxidase reaction (Jeffrey and Echazareta, 1996). Indeed, it 
contributes a slight tartness to the flavor of honey and also adds antimicrobial properties as 
well as increase in calcium absorption.  
 
      In recent years, many studies have been conducted to identify the phytochemicals 
present in honey. Phytochemicals are non-nutrient compounds commonly found in plants 
such as fruits and vegetables (Kuhnle et al., 2009) and have health-promoting activities by 
reducing the risk of oxidative tissue (Aljadi and Kamaruddin, 2004; Al-Mamary et al., 
2002). Honey is well known to be rich in both enzymatic and non-enzymatc antioxidants, 
including catalase, ascorbic acid, flavonoids, alkaloids, glucose oxidase, phenolics acid, 
carotenoid derivatives, Maillard reaction products, amino acid and proteins (Aljadi and 
Kamaruddin, 2004; Al-Mamary et al., 2002; Gheldof and Engeseth, 2002; Gheldof et al., 
2002; 2003; Schramm et al., 2003). Pinocembrin, a unique flavonoid is highly present in 
propolis and honey, while the others such as quercetin, chrysin, galangin, luteolin and 
kaemferol were also reported to be in honey (Gheldof et al., 2002; 2003; Baltrusaityte et 
al., 2007). Previous works have indicated that the antioxidant activity of honey varies 
widely depending on the floral sources (Gheldof and Engeseth, 2002; Gheldof et al., 2002; 
Al-Mamary et al., 2002; Nagai et al., 2001; Bertoncelj et al., 2007; Chen et al., 2000; Yao 
et al., 2004; Frankel et al., 1998). Several studies have shown that a strong correlation 
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between honey colour and antioxidant power, with darker and more crystallized honey 
having higher total phenolic content and hence a stronger antioxidant capacity than lighter 
and transparent honey (Blasa et al., 2006; Nagai et al., 2001; Bertoncelj et al., 2007) as 
well as honey with higher content of water (Aljadi and Kamaruddin, 2004; Frankel et al., 
1998). Moreover, the color of honey depends on the potential alkalinity and ash content, as 
well as on the antioxidatively active pigments, including carotenoids and flavonoids 
(Frankel et al., 1998). 
 
2.1.2 Honey in modern medicinal uses 
 
        Nowadays, ancient remedies still survive together with modern medicine under the 
term ‘modern folk medicine’ since their effectiveness has not been scientifically proven 
through clinical trials. The ancient usage of honey into modern folk medicine has been 
continued in India as a traditional therapy for coughs and sore throats and eye diseases 
(using lotus honey), infected leg ulcers in Ghana, earaches in Nigeria, topical treatment for 
measles and eye measles to prevent corneal scarring, as well as for the treatment of gastric 
ulcers and constipation (Obi et al., 1994; Zumla and Lulat, 1989; Imperato and Traore, 
1969; Ankra-Badu, 1992; Kandil et al., 1987). In Germany, honey with cod liver oil was 
used for treatment of ulcerations, burns, fistulas and boils. During World War I, Russian 
soldiers used honey to prevent infections in wounds as well as to accelerate healing 
(Bergman et al., 1983).  
 
        The mechanism of the effects of honey on human health has gradually became 
apparent in a number of scientific studies. The scientific support has been well documented 
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with a proliferation in publications on the successful therapeutic uses of honey in several 
general medical and surgical conditions (Somerfield, 1991; McInerney, 1990; Armon, 
1980; Zumla and Lulat, 1989; Bergman et al., 1983; Efem, 1988; Grange, 1990; 
Subrahmanyam, 1993; 1994; 1996; 1998; Efem et al., 1992; Phuapradit and Saropala, 
1992; Adesunkanmi and Oyelami, 1994; Hejase et al., 1996; Wood et al., 1997; Ndayisaba 
et al., 1992; Ndayisaba et al., 1993). The most active medical effect of honey is its 
antimicrobial property. The mechanism of this function was due to its high osmolarity 
(Willix et al., 1992), acidity and content of inhibines, such as peroxide (Postmes et al., 
1993; Burdon, 1995; Cooper et al., 1999; Bang et al., 2003; Mani, 2006; Molan, 2001; 
2002; Patton et al., 2006), flavonoids and the phenolic acids (caffeic and ferulic acid) 
(Wahdan, 1998; Frankel et al., 1998; Cao et al., 1997; Baltrusaityte et al., 2007). However, 
the antimicrobial ability of honey differs depending on its floral source (Gheldof and 
Engeseth, 2002; Al-Mamary et al., 2002; Nagai et al., 2001; Bertoncelj et al., 2007; Chen 
et al., 2000; Yao et al., 2004; Frankel et al., 1998) . In 1892, Van Ketel first recognized the 
antimicrobial activity of honey (Dustmann, 1979). Intensive study on the antimicrobial 
activity of honey had began in 1937 and found the antimicrobial name ‘inhibine’ was 
formed (Willix et al., 1992). Later in 1965, other researchers identified ‘inhibine’ as 
hydrogen peroxide, which is formed by enzymatic glucose oxidase reaction. In other 
honeys, the antimicrobial agent is a non-peroxide compound derived directly from the 
flower (Patton et al., 2006) . Therefore, not every type of honey has equally effective 
antimicrobial properties. The antimicrobial and antifungal properties of honey have been 
well documented through several studies. Honey at concentration of 40% found to be 
bactericidal to various gram-negative and gram-positive bacteria particularly Salmonella 
shigella, E. coli and Bibrio cholera (Jeddar et al., 1985). Concentrations of between 30% 
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and 50% of honey were found to be as effective as cephaloridine, ampicilin, gentamycin, 
nitrofurantoin, nalidixic acid and cotrimoxazole in inhibiting growth of nine types of 
pathogenic organisms isolated from the urine samples of 149 patients with confirmed 
urinary tract infection (Ibrahim, 1981).  
 
       Honey has been proven to be effective in treating infected surgical wounds, burns and 
decubitus ulcer. A research found that local application of honey in the postoperative 
management of patients who had undergone radical vulvectomy for vulval carcinoma lead 
to succesfull healing (Cavanagh et al., 1970). The rate of wound healing was accelerated 
and less bacterial colonization was observed. This observation has been proven in an 
animal model  when pure commercially available honey applied on 12 mice significantly 
healed wounds faster than those of the control group (Bergman et al., 1983).  
Subrahmanyam (1998) reported his findings in randomized controlled trial study in which 
honey was found to be more a efficient dressing for burns as compared to silver 
sulfadiazine. Treatment with silver sulfadiazine, the most widely used agent to prevent or 
clear infection in burns, resulted in 7% of the patients controlled from wound infection 
within seven days while treatment with honey resulted in 91% of the wounds to be sterile 
within the same period. Honey was observed to remove dead tissue and offensive smell 
from burns (Hutton, 1966; Efem, 1988). Healthy granulation tissue was observed to appear 
nearly twice as fast when using honey, and new skin cover developed faster also 
(Subrahmanyam, 1998; Hejase et al., 1996). There was also better relief of pain, less 
exudation of lymph and less irritation when using honey. Honey also gave a lower 
incidence of raised scars and contractures. In the literature, honey was reported to 
successfully treat various types of wounds such as abrasions (Blomfield, 1973), 
                                                                                                                                              15
amputations (Hutton, 1966), abscesses (Farouk et al., 1988), bed sores (pressure sores, 
decubitus ulcers) (Weheida et al., 1991; Somerfield, 1991; Efem, 1988), burns (Ndayisaba 
et al., 1993; Efem, 1988; Blomfield, 1973; Farouk et al., 1988; Adesunkanmi and Oyelami, 
1994; Subrahmanyam, 1993; 1994; 1996; 1998), burst abdominal wounds following 
caesarean delivery (Phuapradit and Saropala, 1992), cancrum (Efem, 1988), cervical ulcers, 
chilblains, cracked nipples (Seymour and West, 1951), cuts (Blomfield, 1973), diabetic foot 
ulcers and other diabetic ulcers (Tovey, 1991; Farouk et al., 1988), a fistula , foot ulcers in 
lepers (Tovey, 1991), infected wounds arising from trauma (Efem, 1988; Ndayisaba et al., 
1993), large septic wounds, leg ulcers, malignant ulcers, sickle cell ulcers, tropical ulcers 
(Efem, 1988), skin ulcers (Tovey, 1991; Blomfield, 1973; Efem, 1988), surgical wounds 
(Bergman et al., 1983; Farouk et al., 1988; Ndayisaba et al., 1993; Cavanagh et al., 1970), 
wounds to the abdominal wall and perineum and varicose ulcers (McInerney, 1990). Of 
particular notice is the success of honey in treating Fournier’s gangrene, a rapidly spreading 
infection that is usually managed by aggressive surgical removal of infected tissue (Efem 
1988, 1993). 
 
       Honey has also been used for a long time in the treatment of various gastrointestinal 
diseases. The effect was proven when an oral rehydration therapy (ORT) solution 
containing 5% honey was given to infants and children suffering from bacterial 
gastroenteritis (Salmonella, Shigella and E.coli) (Haffejee and Moosa, 1985; Jeddar et al., 
1985). The convincing results showed that recovery time from bacterial diarrhea was 
significantly faster in patients given ORT solution containing equal concentration of 
glucose and concluded that honey can safely be used as a substitute for glucose in solution 
with electrolytes and in promoting sodium and water from the gut. Based on these data, 
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honey can provide an effective and cheap therapy for infected wounds and infectious 
gastrointestinal diseases. However, honey is a natural mixture of carbohydrates that may be 
contaminated with spores of Clostridium botulinum (Arnon, 1980,1979; Midura et al., 
1979) that can result in infant botulism and harmful effects to wound dressing. Sterilization 
of honey for these usages would eliminate this risk. However, the antibacterial activity of 
honey can be lost with standard sterilization procedures such as autoclaving, therefore 
gamma-radiation is the other alternative method since it does not affect its bactericidal 
activity (Molan and Allen, 1996). Hence, investigators who use honey must be aware of 
these potential complications associated with such treatments. 
 
       Nowadays, there are lots of research that has been conducted in Malaysia on honey, 
particularly by Universiti Sains Malaysia (USM) on the local wild honey known as the 
Tualang honey. The 1st International Conference on the Medicinal Uses of Honey in 2006 
and 2nd International Conference on the Medicinal Uses of Honey in 2010 which were 
mainly organized by Universiti Sains Malaysia had successfully gathered the recent 
findings of clinical and laboratory studies from all over world. Some of the findings that 
were presented in these conferences were that Tualang honey has an important role in 
improvement of reproductive system in postmenopausal animal model (Siti Sarah et al., 
2007a,b) and male rats exposed to cigarette smoke (Mahaneem et al., 2007a,b). It was also 
found that daily intake of Tualang honey at 20 mg/day for 4 months has similar effect on 
bone densitometry when compared with hormone replacement therapy (Lily Husniata et al., 
2010). Besides that, it was reported that Tualang honey has wound contraction and 
antimicrobial properties on full thickness burn wound in rats (Halima et al., 2010).  
Combination of Tualang honey supplementation and jumping exercise may also elicit 
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beneficial effects on tibial bone mineral density (Kiew et al., 2010). Tualang honey also has 
antiproliferative and apoptotic effect on oral squamous cell carcinoma and human 
osteosarcoma cell lines (Gashm et al., 2010) and is also potentially used as therapeutic 
agent for diabetic foot wounds (Nawfar et al., 2010), Tualang honey might reduce 
hyperglycemia, ameliorates oxidative stress and protects STZ-induced diabetic renal 
damage (Erejuwa et al., 2010). Honey is an effective agent against yeast infections (Tuan 
Noorkorina and Mazatul Haizam, 2010) and can reduce apoptosis in leukemia cells 
(Rosline et al., 2010), phenolic contents and antioxidant capacity (Khalil et al., 2010). Last 
but not least, it was found that Tualang honey was significantly effective as a prophylactic 
measure in reducing acute respiratory symptoms among Hajj pilgrims (Siti Amrah et al., 
2010).        
        
       In recent years, attention has highly focused on natural food as nutraceuticals that have 
been used for the treatment of illnesses and diseases from ancient times. The mechanism of 
the effect of honey on human health has gradually become apparent in a number of studies. 
Many researchers demonstrated that honey contains a rich source of natural antioxidants 
and phytochemicals, which are effective in reducing the risk of heart disease, cancer, 
immune-system decline, cataracts, different inflammatory processes, as anti-allergic, anti-
thrombotic, vasodilatory actions as well as its impact on gastrointestinal  health and energy 
metabolism (Bertoncelj et al., 2007). Some suggested that oxidative and free radical-
mediated reactions are implicated in degenerative processes related to aging with or without 
various diseases (Cerutti, 1994; Dean et al., 1993) such as cancer, atherosclerosis, immune 
system decline, cataracts, diabetes etc (Bertoncelj et al., 2007; Blasa et al., 2006). 
According to Heim et al (2002), several polyphenols have been reported to quench reactive 
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oxygen species (ROS) and inhibit in vitro oxidation of low-density lipoproteins (LDL) and 
therefore reduce thrombotic tendency that is provided by endogenous antioxidants or by an 
array of different compounds contained in the diet (Manach et al., 2004) while the others 
reported that diet rich in antioxidants would protect vital cell components from oxidative 
damage and slow down the aging process by neutralizing free radicals (Blasa et al., 2007). 
 
       Honey also has been reported to prevent deteriorative oxidation reactions in foods such 
as enzymatic browning of fruit and vegetables (Chen et al., 2000), lipid oxidation in meat 
(Nagai et al., 2006; Gheldof and Engeseth, 2002; McKibben and Engeseth, 2002) and 
inhibit the growth of foodborne pathogens and spoilage organisms (Mundo et al., 2004; 
Taormina et al., 2001). A study has identified several key nutrients (namely, potassium, 
magnesium, fiber, β-carotene and vitamin C) which could be implicated in bone health 
(New et al., 2000), while other researchers claimed that phytochemicals in several plants 
and fruits may contribute beneficial effects in postmenopausal animal model by showing an 
improvement in bone health, reproductive organs and exerting hormonal balancing effect 
(Devareddy et al., 2006; Mori-Okamoto et al., 2004; Puel et al., 2006; Puel et al., 2005; 
Shirwaikar et al., 2003; Zhang et al., 2007; Zhang et al., 2006b). Royal jelly, which is one 
of the beehive products has been proven by a laboratory study to prevent osteoporosis in 
ovariectomised rats by enhancing intestinal calcium absorption (Nagai and Inoue, 2004). 
Royal jelly and propolis are beehive products that have been scientifically proven for their 
improvement of menopausal syndrome (Mishima et al., 2005; Song et al., 2002). 
Interestingly, honey contains all of these mentioned bioactive compounds such as 
polyphenols and flavonoids (Aljadi and Kamaruddin, 2004), the key nutrients for bone 
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health and phytochemicals which may be beneficial in relieving postmenopausal symptoms 
(Al-Mamary et al., 2002).  
 
       To the researcher’s knowledge, even though honey is traditionally well known to 
improve postmenopausal symptoms, there has been no research conducted to evaluate the 
effectiveness of honey in alleviating or improving postmenopausal symptoms. Therefore, 
this study was conducted to evaluate the efficacy of Tualang honey (AgroMas, Malaysia) in 
preventing some of the postmenopausal symptoms using ovariectomised rats as the 
postmenopausal animal model. The parameters assessed in this study include general 
health, body weight, food intake, reproductive organs (vagina and uterus), reproductive 
hormonal levels, bone properties and fasting blood glucose level.   
 
2.1.3 Tualang honey (AgroMas, Malaysia) 
 
       The Tualang honey used in this study was supplied by Federal Agricultural Marketing 
Authority (FAMA), Kedah, Ministry of Agriculture and Agro-Based Industry. Tualang 
honey is produced by bees (Apis Dorsata) in which their hives are built hanging under the 
branch of Tualang tree at Sik, Kuala Nerang and Baling forest in Kedah. Tualang honey is 
collected from forests where the levels of dangerous chemicals in the atmosphere are 
insignificant and the environmental pollution is minimal. Furthermore, it is kept by the Apis 
Dorsata in fixed comb log and hives wall without the use of artificial comb foundations, 
sugar feeding and antibiotics in such hives. Therefore, Tualang honey is considered as 
Malaysian pure wild honey with dark color. Interestingly, honey that is produced by Apis 
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